Cost-effectiveness of anti-oxidant vitamins plus zinc treatment to prevent the progression of intermediate age-related macular degeneration. A Singapore perspective

about

Burden of Wet Age-Related Macular Degeneration and Its Economic Implications in Singapore in the Year 2030.Early and intermediate age-related macular degeneration: update and clinical review.

P2860

Q38848894-148A80C5-A7D9-43C4-BCEC-9784DB37B4E8 Q42373141-1289D26A-DE36-4E72-94E5-F5642A9FE434

P2860

Cost-effectiveness of anti-oxidant vitamins plus zinc treatment to prevent the progression of intermediate age-related macular degeneration. A Singapore perspective

Item

http://www.wikidata.org/entity/Q35999663

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cost-effectiveness of anti-oxi ...... ation. A Singapore perspective

@ast

Cost-effectiveness of anti-oxi ...... ation. A Singapore perspective

@en

type

Item

label

Cost-effectiveness of anti-oxi ...... ation. A Singapore perspective

@ast

Cost-effectiveness of anti-oxi ...... ation. A Singapore perspective

@en

prefLabel

Cost-effectiveness of anti-oxi ...... ation. A Singapore perspective

@ast

Cost-effectiveness of anti-oxi ...... ation. A Singapore perspective

@en

P1476

Cost-effectiveness of anti-oxi ...... ation. A Singapore perspective

@en

P2093

Bee Hoon Heng

http://www.w3.org/2001/XMLSchema#string

Nakul Saxena

http://www.w3.org/2001/XMLSchema#string

Pradeep Paul George

http://www.w3.org/2001/XMLSchema#string

Shao Onn Yong

http://www.w3.org/2001/XMLSchema#string

Tock Han Lim

http://www.w3.org/2001/XMLSchema#string

P2860

A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus goldstandard

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

Global data on visual impairment in the year 2002

Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).

The burden of age-related macular degeneration: a value-based medicine analysis

Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.

Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins.

Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants.

P304

516-523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0301-4738.158533

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26265643

http://www.w3.org/2001/XMLSchema#string

P921

Singapore

P932

4550985

http://www.w3.org/2001/XMLSchema#string

Cost-effectiveness of anti-oxidant vitamins plus zinc treatment to prevent the progression of intermediate age-related macular degeneration. A Singapore perspective

about

P2860

P2860

Cost-effectiveness of anti-oxidant vitamins plus zinc treatment to prevent the progression of intermediate age-related macular degeneration. A Singapore perspective

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932